Predictors of disease severity in patients hospitalized with coronavirus disease 2019
- PMID: 37554023
- PMCID: PMC10716835
- DOI: 10.5144/0256-4947.2023.254
Predictors of disease severity in patients hospitalized with coronavirus disease 2019
Abstract
Background: Coronavirus disease 2019 (COVID-19), caused by a novel coronavirus, manifests as a respiratory illness primarily and symptoms range from asymptomatic to severe respiratory syndrome and even death. During the pandemic, due to overcrowding of medical facilities, clinical assessment to triage patients for home care or in-hospital treatment was an essential element of management.
Objectives: Study the demographic features, comorbidities and bio-markers that predict severe illness and mortality from COVID-19 infection.
Design: Retrospective observational SETTING: Single tertiary care center PATIENTS AND METHODS: The study included all patients admitted with a positive PCR test for COVID-19 during the period from March 2020 to September 2020 (7 months). Data on demographics, clinical data and laboratory parameters was collected from medical records every 3 days during hospital stay or up until transfer to ICU.
Main outcome measures: Demographic, comorbidities and biochemical features that might predict severe COVID-19 disease.
Sample size: 372 RESULTS: Of the 372 patients, 72 (19.4%) had severe disease requiring admission to intensive care unit (ICU); 6 (1.6%) died. Individuals over 62 years were more likely to be admitted to the ICU (P=.0001, while a BMI of 40 and higher increased the odds of severe disease (P=.032). Male gender (P=.042), hypertension (P=.006) and diabetes (P=.001) conferred a statistically significant increased risk of admission to ICU, while coexisting COPD, and ischemic heart disease did not. Laboratory features related to severe COVID-19 infection were: leukocytosis (P=.015), thrombocytopenia (P=.001), high levels of C-reactive protein (P=.0001), lactic dehydrogenase (P=.0001), D-dimer (P=.0001) and ferritin (P=.001). With the multivariate analysis, diabetes, high lac-tate dehydrogenase, C-reactive protein and thrombocytopenia were associated with severity of illness.
Conclusions: Particular demographic and clinical parameters may predict severe illness and need for ICU care.
Limitations: Single referral center, several cases of severe COVID-19 could not be included due to lack of consent and or data.
Conflict of interest: None.
Conflict of interest statement
None.
Similar articles
-
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9. Trials. 2020. PMID: 33115543 Free PMC article.
-
Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.Cureus. 2020 Sep 29;12(9):e10716. doi: 10.7759/cureus.10716. Cureus. 2020. PMID: 33033687 Free PMC article.
-
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.Clin Rheumatol. 2020 Sep;39(9):2789-2796. doi: 10.1007/s10067-020-05301-2. Epub 2020 Jul 27. Clin Rheumatol. 2020. PMID: 32720259 Free PMC article.
-
Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.Am J Infect Control. 2021 Jan;49(1):82-89. doi: 10.1016/j.ajic.2020.06.008. Epub 2020 Jun 12. Am J Infect Control. 2021. PMID: 32540370 Free PMC article. Review.
-
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.Eur J Clin Invest. 2020 Oct;50(10):e13362. doi: 10.1111/eci.13362. Epub 2020 Aug 27. Eur J Clin Invest. 2020. PMID: 32726868
References
-
- WHO Coronavirus (COVID-19) Dashboard (https://covid19.who.int/ (October 6, 2022)
-
- Wu J, Li W, Shi X, Chen Z, Jiang B, Liu J,. et al.. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19). Journal of internal medicine. 2020. Jul;288(1):128–38. - PubMed
-
- Guo Z, Zhang Z, Prajapati M, Li Y. Lymphopenia Caused by Virus Infections and the Mechanisms Beyond. Viruses. 2021. Sep 20;13(9):1876. doi: 10.3390/v13091876. PMID: 34578457; PMCID: PMC8473169. - DOI - PMC - PubMed
-
- Figliozzi S, Masci PG, Ahmadi N, Tondi L, Koutli E, Aimo A,. et al.. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Eur J Clin Invest. 2020. Oct;50(10): e13362. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials